Clinical Trial Update: A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency [Phase 2]

View source ↗

Summary

Phase 2 safety, pharmacokinetic and pharmacodynamic study of TransCon hGH (ACP-001) in adults with growth hormone deficiency has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• TransCon hGH (ACP-001)

Snippet

Sponsor: Ascendis Pharma A/S | Conditions: Adult Growth Hormone Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2017-03-09